Monocyte subsets predict mortality after cardiac arrest

Area of Science:

• Immunology
• Critical Care Medicine
• Cardiology

Background:

• Post-successful cardiopulmonary resuscitation (CPR), patients often exhibit heightened immune activation.
• Monocytes, key immune cells, comprise distinct subsets: classical (CM), intermediate (IM), and non-classical (NCM), identifiable by flow cytometry.
• Understanding these monocyte subsets may offer insights into post-cardiac arrest outcomes.

Purpose of the Study:

• To investigate the association between monocyte subset distribution and clinical outcomes in patients following cardiac arrest.
• To determine if specific monocyte subsets can predict survival and neurological function at 6 months post-cardiac arrest.

Main Methods:

• A cohort of 53 medical intensive care unit (ICU) patients admitted after cardiac arrest was studied.
• Blood samples were collected on ICU admission and at 72 hours.
• Monocyte subsets (CM, IM, NCM) were analyzed using flow cytometry, with primary endpoints of 6-month survival and neurological outcome (CPC score).

Main Results:

• Six-month mortality was 50.9%, with 37.7% achieving good neurological outcome.
• Monocyte subset distribution on admission did not correlate with survival.
• At 72 hours, non-survivors showed a higher percentage of pro-inflammatory IM and a lower percentage of CM compared to survivors.
• IM subset levels independently predicted outcome and correlated with the cerebral performance category (CPC) score.

Conclusions:

• The distribution of monocyte subsets, particularly the pro-inflammatory IM, changes significantly by 72 hours post-cardiac arrest in non-survivors.
• Intermediate monocytes may serve as a predictive biomarker for outcomes in post-cardiac arrest patients.
• These findings highlight a potential role for the innate immune system in the pathophysiology of post-cardiac arrest syndrome.